Article · AI Assurance

An AI reviewer can save time and still weaken a review

How to evaluate an AI-assisted review using missed issues, false findings and the final human decision.

CSVtoCSA editorial · 2 min read · Published · Summary updated 2026-09-21 · Version 1.1

An assistant produces a list of protocol findings in seconds. The reviewer finishes faster. That looks promising, but time alone does not establish whether the review improved.

The assistant might help the reviewer find a subtle unit mismatch. It might also distract the reviewer with false findings or create an impression that everything outside the generated list has already been checked.

Examine the final decision

Fictional example. An evaluation set contains 40 reference issues. The assistant identifies 32 and misses 8, including 2 critical issues. Its proposed findings include 6 false findings. A human may correct those errors, but that must be evaluated rather than assumed.

If reviewers accept false findings and miss the same critical issues, the combined workflow does not become adequate merely because a person clicked approve. If reviewers identify additional issues and reject unsupported suggestions, that is useful evidence about the combined process, subject to the study’s design and limits.

Count the full effort

Include time spent preparing inputs, reviewing sources, dismissing false findings, correcting output, documenting decisions, and resolving tool failures. Record whether different experience levels affect outcomes. A demonstration by the developer is not the same as use by representative reviewers.

Protect the comparison

Use a planned evaluation with suitable cases and a fair comparison. Consider assignment order, learning effects, repeated templates, and independent adjudication. Preserve unfavorable findings. Describe uncertainty and avoid claiming that an informal pilot proves a general improvement.

Improve the workflow

Make sources accessible. Avoid language that promises completeness. Keep the assistant’s authority narrow. Train reviewers to challenge plausible output and to perform the required review. Evaluate those controls under representative conditions.

A useful AI reviewer is one whose role and limitations are understood and whose contribution is supported by evidence. Fast generation is an input to that evaluation, not its conclusion.

Practitioner interpretation; apply the sources within their scope and follow your approved procedures. Prepared with AI assistance and editorial responsibility. Original publication and source links are retained; this revision updates the summary and resource navigation.

Relevant regulations and guidance

These sources apply within their stated scope. The suggested worksheet fields, test designs and fictional decisions are practitioner recommendations, unless a source requirement is expressly identified. Completing a template does not establish compliance.

Computer Software Assurance for Production and Quality Management System Software ↗

Regulatory guidance / GMP guideline · United States · February 2026

Scope: Medical-device manufacturers assuring software used in production or their quality management system.

Relevance: For medical-device production or QMS software, supports selecting assurance activities from intended use, risk and available evidence. It is nonbinding guidance and does not determine other sectors’ obligations.

Status: Final / published · Checked 2026-09-21

Publication identity, scope and status checked against the linked official source. This is not an independent audit of every retained guide statement.

Read source details and applicability →

EudraLex Volume 4, Annex 11 — Computerised Systems ↗

Regulatory guidance / GMP guideline · European Union · January 2011 revision

Scope: Computerised systems supporting activities in the applicable EU pharmaceutical GMP context.

Relevance: For computerised systems used in EU GMP activities, informs lifecycle, supplier and record controls. Confirm applicability to the actual activity; the example does not establish it.

Status: Final / published · Checked 2026-09-21

The Commission index confirms the January 2011 operative revision. The linked PDF could not be retrieved in this check; retained detailed section mappings need review against an authorized copy.

Read source details and applicability →

Artificial Intelligence Risk Management Framework (AI RMF 1.0) and NIST AI 600-1 ↗

Industry guidance / framework · United States · AI RMF 1.0 (2023); GenAI Profile (2024)

Scope: Cross-sector AI governance and risk management, including generative AI.

Relevance: A voluntary framework for describing AI risks, evaluation and ongoing management. Its suggested practices are not regulatory requirements.

Status: Final / published · Checked 2026-09-21

Publication identity, scope and status checked against the linked official source. This is not an independent audit of every retained guide statement.

Read source details and applicability →
Was this useful? Leave feedback

Was this resource useful?

Tell us what helped and what could be clearer. Usefulness feedback does not establish technical validity or regulatory compliance.

Loading contribution options…

Questions and moderated discussion

Questions and discussion

Ask a question or share a perspective. Contributions are reviewed before publication.

Loading contribution options…

Suggest a correction

Sent privately to the editorial moderation queue. Your account email and correction are not published as a comment. Do not include confidential or personal information.

Resource: An AI reviewer can save time and still weaken a review

Loading sign-in status…

Correction details